LONDON, Jan. 19, 2016 /PRNewswire/ -- In a world first, BNY Mellon and Newton Investment Management, sponsors of The Boat Races, today announce they are donating their title sponsorship of the annual challenge between Oxford and Cambridge Universities to Cancer Research UK (CRUK), the official charity partner.
The event will now be known as The Cancer Research UK Boat Races with a new identity that will incorporate the famous Dark Blue of Oxford and Light Blue of Cambridge with the charity's distinctive magenta and blue. The campaign will see Cancer Research UK receive substantial exposure throughout the Races, which will take place on the Championship Course on the River Thames between Putney and Mortlake on 27th March.
BNY Mellon and Newton Investment Management will work together with Cancer Research UK to support their fundraising activities in the build up to The Boat Races and will also be implementing their own initiatives with all fundraising in aid of Cancer Research UK.
Curtis Arledge, Vice Chairman of BNY Mellon and CEO of Investment Management, commented: "We are committed to ensuring our sponsorship of The Boat Races reflects our focus on meaningful investments, especially when we can leverage our sponsorship to further effect change. We are proud to be working with Cancer Research UK, whose work touches the lives of so many.
"We have the opportunity to be a sponsorship partner that genuinely changes people's lives for the better through sport. Just as the four crews from Oxford and Cambridge will pull together to battle for glory on the water, BNY Mellon, Newton Investment Management and Cancer Research UK are pulling together to fight cancer."
Helena Morrissey, Chief Executive Officer of Newton Investment Management, added: "We are delighted to be trailblazing a whole new model for corporate sponsorship. The role of business in society is clear: in addition to performing well for customers and shareholders, we can and must use our resources to help solve difficult problems. We hope this news encourages other companies around the world to follow suit and that together, we can make a genuine difference."
David Searle, Executive Director of The Boat Race Company Ltd said: "In BNY Mellon and Newton Investment Management we knew we had sponsors who would do something out of the ordinary. After making history with the introduction of The Women's Boat Race to the Tideway in 2015, this amazing gesture is breaking new ground in sponsorship. We are very grateful to BNY Mellon and Newton Investment Management for this move and for their commitment to support their gesture by helping to raise significant sums of money for Cancer Research UK through the various events they are developing with us and the team at CRUK."
Sir Harpal S. Kumar, Chief Executive of Cancer Research UK, said: "We are enormously grateful to BNY Mellon and Newton Investment Management for their generous donation. Cancer Research UK's work has fuelled the progress that has seen cancer survival rates double in the last 40 years. Today, two in four people survive cancer. Our ambition is to accelerate progress so that three in four people survive cancer by 2034 and this donation is a very welcome contribution to that aim."
Earlier this month, Cancer Research UK launched The Great Row – a new fitness challenge, which is completed on indoor rowing machines and encourages the nation to dust off their trainers and take part to help beat cancer sooner. To take part in The Great Row, individuals and teams can choose from different challenge levels; with rowing distances starting from 2,000 metres, going up to a full marathon. Participants can train for free at Fitness First gyms every Friday throughout January, February and March, with The Great Row's official fitness partner welcoming participants every day from 19th – 26th March to complete their challenge ahead of the official races.
The Cancer Research UK Boat Races will take place on Sunday 27th March 2016. The Cancer Research UK Women's Boat Race will take place at 3.10pm GMT and The Cancer Research UK Boat Race at 4.10pm GMT.
To get involved, please follow @BNYMellonRaces #PullTogether
NOTES TO EDITORS:
Newton Investment Management is a London-based global investment management subsidiary of The Bank of New York Mellon Corporation. With assets under management of £45.2 billion (as at September 30, 2015), including assets managed by Newton Investment Management Limited as dual officers of Newton Capital Management Limited and The Bank of New York Mellon, Newton's group of affiliated companies provides investment products and services to a wide range of clients, including pension funds, charities, corporations and (via BNY Mellon) individuals. News and other information about Newton are available at www.newton.co.uk and via Twitter: @NewtonIM.
BNY Mellon Investment Management is one of the world's leading investment management organisations and one of the top US wealth managers, with $1.6 trillion in assets under management. It encompasses BNY Mellon's affiliated investment management firms, wealth management services and global distribution companies. More information can be found at www.bnymellon.com.
BNY Mellon is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle. Whether providing financial services for institutions, corporations or individual investors, BNY Mellon delivers informed investment management and investment services in 35 countries and more than 100 markets. As of September 30, 2015, BNY Mellon had $28.5 trillion in assets under custody and/or administration, and $1.6 trillion in assets under management. BNY Mellon can act as a single point of contact for clients looking to create, trade, hold, manage, service, distribute or restructure investments. BNY Mellon is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK). Additional information is available on www.bnymellon.com. Follow us on Twitter @BNYMellon or visit our newsroom at www.bnymellon.com/newsroom for the latest company news.
About The Boat Races The Boat Race is a major London event which takes place on the River Thames over 4¼ miles between Putney and Mortlake in the University Easter holidays. The first Race took place in 1829 and it has been held every year since 1856 with the exception of the two World Wars. The current score between the two men's Clubs is Cambridge 81, Oxford 79 with one dead heat.
The first Women's Boat Race took place in 1927 in the form of a time and style contest. Since then, the Oxford and Cambridge University Women's Boat Clubs have competed annually. In 2015, following a decision by The Boat Race Company Ltd and with the invaluable help of BNY Mellon and Newton Investment Management, it relocated to The Championship Course from Putney to Mortlake to compete on the same day as the men across the same course. The current score between the two women's Clubs is Cambridge 41, Oxford 29.
About Cancer Research UK
- Cancer Research UK was announced as the official charity partner of The Boat Races in October 2015
- Cancer Research UK is the world's leading cancer charity dedicated to saving lives through research.
- Cancer Research UK's pioneering work into the prevention, diagnosis and treatment of cancer has helped save millions of lives.
- Cancer Research UK receives no government funding for its life-saving research. Every step it makes towards beating cancer relies on every pound donated.
- Cancer Research UK has been at the heart of the progress that has already seen survival rates in the UK double in the last forty years.
- Today, two in four people survive cancer. Cancer Research UK's ambition is to accelerate progress so that three in four people will survive cancer within the next 20 years.
- Cancer Research UK supports research into all aspects of cancer through the work of over 4,000 scientists, doctors and nurses.
- Together with its partners and supporters, Cancer Research UK's vision is to bring forward the day when all cancers are cured.
This press release is issued by The Bank of New York Mellon to members of the financial press and media. All information and figures source BNY Mellon unless otherwise stated as at release is qualified for issuance in the UK and Europe and is for information purposes only. It does not constitute an offer or solicitation of securities or investment services or an endorsement thereof in any jurisdiction or in any circumstance in which such offer or solicitation is unlawful or not authorized. Any views and opinions contained in this document are those of the investment manager, unless otherwise noted. This press release is issued by BNY Mellon Investment Management (US) and BNY Mellon Investment Management EMEA Limited (BNYMIM EMEA) to members of the financial press and media and the information contained herein should not be construed as investment advice. The value of investments and the income from them is not guaranteed and can fall as well as rise due to stock market and currency movements. When you sell your investment you may get back less than you originally invested. Registered office of BNYMIM EMEA: BNY Mellon Centre, 160 Queen Victoria Street, London, EC4V 4LA. Registered in England no. 1118580. Authorized and regulated by the Financial Conduct Authority. A BNY Mellon Company.
BNY Mellon & Newton Aarti Parekh 07792 715 053 firstname.lastname@example.org
Cancer Research UK Issy Evans 0203 469 8302 email@example.com
The Boat Races Maria O'Connor 07921 603 987 firstname.lastname@example.org
SOURCE BNY Mellon